| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
52,169 |
31,293 |
$6.45M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
38,870 |
25,948 |
$4.97M |
| 59840 |
|
3,012 |
3,000 |
$2.21M |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
14,583 |
12,874 |
$1.63M |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
2,026 |
2,022 |
$1.57M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,980 |
7,226 |
$1.22M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
7,487 |
5,756 |
$1.13M |
| J7300 |
Intrauterine copper contraceptive (paragard) |
1,240 |
1,235 |
$809K |
| 11976 |
|
1,061 |
1,058 |
$619K |
| S0190 |
Mifepristone, oral, 200 mg |
8,036 |
8,003 |
$506K |
| 11981 |
|
1,580 |
1,576 |
$467K |
| 58300 |
|
2,818 |
2,654 |
$428K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,207 |
1,973 |
$424K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
8,145 |
8,103 |
$424K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,687 |
3,585 |
$418K |
| 99201 |
|
3,532 |
1,690 |
$326K |
| 58301 |
|
1,711 |
1,676 |
$270K |
| 86703 |
|
14,932 |
14,857 |
$220K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,146 |
9,769 |
$135K |
| 99051 |
|
11,128 |
10,630 |
$134K |
| J7296 |
Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg |
240 |
240 |
$132K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
608 |
599 |
$115K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
114 |
113 |
$96K |
| 81025 |
|
29,406 |
28,616 |
$91K |
| 90651 |
|
444 |
444 |
$83K |
| 11982 |
|
251 |
249 |
$78K |
| 99385 |
|
292 |
292 |
$64K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
180 |
180 |
$38K |
| S0191 |
Misoprostol, oral, 200 mcg |
7,877 |
7,812 |
$13K |
| 99000 |
|
1,924 |
1,849 |
$11K |
| 57454 |
|
15 |
15 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
1,224 |
1,124 |
$6K |
| 36416 |
|
337 |
337 |
$6K |
| 99215 |
Prolong outpt/office vis |
67 |
13 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$3K |
| 76830 |
Ultrasound, transvaginal |
30 |
29 |
$2K |
| 85018 |
|
2,934 |
2,825 |
$1K |
| 87210 |
|
4,313 |
4,237 |
$852.85 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
59 |
17 |
$737.50 |
| 90674 |
|
34 |
34 |
$592.88 |
| 81002 |
|
1,635 |
1,580 |
$483.74 |
| 86850 |
|
12 |
12 |
$473.23 |
| 0031A |
|
24 |
24 |
$453.23 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
903 |
897 |
$262.02 |
| J2788 |
Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) |
13 |
13 |
$134.05 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
26 |
26 |
$85.72 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
392 |
390 |
$85.69 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
117 |
116 |
$44.77 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
54 |
54 |
$13.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
54 |
54 |
$13.00 |
| 81001 |
|
148 |
141 |
$0.00 |
| 91301 |
|
21 |
21 |
$0.00 |
| 91303 |
|
24 |
24 |
$0.00 |